WEC
PMD

Winslow Evans & Crocker’s Psychemedics Corporation PMD Stock Holding History

Winslow Evans & Crocker’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2,500
Closed -$61.7K – 1284
2016
Q4 		$61.7K Hold
2,500
– – 0.02% 488
2016
Q3 		$49.5K Buy
2,500
+500
+25% +$9.27K 0.01% 541
2016
Q2 		$27.5K Hold
2,000
– – 0.01% 632
2016
Q1 		$27.5K Buy
2,000
+1,600
+400% +$18.3K 0.01% 627
2015
Q4 		$4.06K Hold
400
– – ﹤0.01% 1104
2015
Q3 		$4.02K Hold
400
– – ﹤0.01% 1072
2015
Q2 		$5.93K Hold
400
– – ﹤0.01% 1045
2015
Q1 		$6.64K Hold
400
– – ﹤0.01% 973
2014
Q4 		$6.06K Hold
400
– – ﹤0.01% 997
2014
Q3 		$5.66K Hold
400
– – ﹤0.01% 1044
2014
Q2 		$5.66K Hold
400
– – ﹤0.01% 998
2014
Q1 		$6.85K Hold
400
– – ﹤0.01% 948
2013
Q4 		$6K Buy
+400
New +$5.5K ﹤0.01% 1102

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Winslow Evans & Crocker's PMD Position: Q1 2017 in Review

Winslow Evans & Crocker sold out of Psychemedics Corporation (PMD) in Q1 2017, closing a stake of 2,500 shares — an estimated $61.7K sold.

Winslow Evans & Crocker first reported a position in PMD in Q4 2013 and held it in 13 quarters. The position peaked at $61.7K in Q4 2016. 53 funds tracked by Wall St. Rank hold PMD as of Q1 2017.

  • Winslow Evans & Crocker reported no remaining Psychemedics Corporation position as of Q1 2017 after selling out during the quarter.
  • Winslow Evans & Crocker sold 2,500 Psychemedics Corporation shares in Q1 2017, an estimated $61.7K.
  • Winslow Evans & Crocker first reported a position in Psychemedics Corporation in Q4 2013 and held it in 13 quarters.
  • Winslow Evans & Crocker's Psychemedics Corporation position peaked at $61.7K in Q4 2016.
  • 53 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2017.

Based on Winslow Evans & Crocker's 13F filing for Q1 2017, filed 14 Apr 2017.